Meet Our Attorneys

CTTG’s attorneys have extensive experience in technology transfer. As technology transfer professionals at the National Institutes of Health, they assisted government scientists and researchers to establish partnerships with industry for the development of a wide range of technology. In private practice they have represented pharmaceutical companies, medical device and dietary supplement manufacturers, law firms, and academic medical centers on technology transfer matters and regulatory issues concerning the clinical research and development of drugs, medical devices, natural products, and dietary supplements.


Kate Duffy Mazan, Esq.Kate Duffy Mazan, Esq.
Member

kmazan@cttg-law.com

Kate Duffy Mazan is an attorney in private practice in McLean, VA. She is the founding member of The Clinical Technology Transfer Group (CTTG). CTTG is a law firm concentrating in technology transfer and regulatory compliance in the clinical setting.

For the past 20 years Kate has practiced exclusively in the area of food and drug law with an emphasis on the regulation of clinical research. In private practice she has assisted a variety of companies and institutions in complying with federal and state laws and regulations governing the conduct of clinical trials. Kate has extensive experience in the negotiation of clinical trial agreements and the regulatory review of clinical research practices. Prior to entering private practice, Kate worked for nine years at the National Cancer Institute (NCI) within the National Institutes of Health. As a technology transfer professional at NIH she managed the intellectual property portfolio of NCI’s Natural Products Branch, negotiating CRADAs and international agreements with countries in Africa, Central and South America, and the Pacific rim. Kate also worked with scientists from several other institutes within NIH to develop a wide range of technology. She began her career at NIH as Chief of NCI’s Cancer Information Service (CIS), a nationwide network of cancer information and education programs located at major cancer centers across the country. In that capacity she was responsible for developing a training program on the conduct of clinical trials to assist information specialists explain clinical research to patients and the public.

Kate holds a law degree from the Columbus School of Law at the Catholic University of America, Washington, D.C., a Master of Science in Public Health Administration from the University of Massachusetts Amherst, and an A.B. from Stonehill College, North Easton, Massachusetts. Kate is admitted to practice law in Virginia, Maryland, and the District of Columbia.


Nancy E. Siegel, Esq.
Nancy E. SiegelOf Counsel

nsiegel@cttg-law.com

Nancy brings a uniquely diverse background in regulatory practice in regulated industry. For over ten years Nancy was a legislative and regulatory counsel for the American Insurance Association. She had responsibility for a diverse portfolio of regulatory practice areas, including rate making, regulatory compliance, automobile insurance, anti-trust, surplus lines and surety. Nancy regularly advised representatives of large nationwide property/casualty insurance companies, lobbyists, and regulators on a full array of regulatory issues in these areas. She had responsibility for testifying before state legislatures and regulatory agencies on legislative and regulatory initiatives affecting member companies, and developed and communicated policy positions to industry lobbyists and regulators. She coordinated policy with industry organizations, specialty boards, trade associations, and major insurance companies. Nancy also published a comprehensive 50-state survey and analysis of property/casualty insurance rate laws as well as a similar guide for workplace drug testing laws.


Sharon Tasman Prysant, Esq.
Sharon T. PrysantOf Counsel

sprysant@cttg-law.com

Sharon Tasman Prysant, Of Counsel to CTTG,  has over 20 years of legal experience and expands the expertise of CTTG to include large scale corporate transactions.   She combines 15 years of practice at Hogan Lovells, one of the 10 largest law firms in the world, with practice at a prestigious communications boutique firm, as well as in-house experience at MedImmune, the global biologics arm of AstraZeneca.

Sharon has represented domestic and international clients, from startups to multinational companies, in the areas of:  technology and intellectual property development, acquisition, protection, and commercialization (including computer information systems, telecommunications, and engineering); consulting and other business services agreements; and life sciences counseling and transactions (including clinical studies, sponsored research and technology transfer for biotechnology, medical device and pharmaceutical companies).

Sharon has a proven ability to negotiate complex contracts and manage large-scale transactions from inception through completion, including transactions exceeding $200,000,000. Sharon also has extensive experience creating comprehensive suites of template agreements to enable clients to manage contracting cost-effectively.  In addition, Sharon has developed and conducted training for clients on a variety of legal issues.

Sharon attended Rensselaer Polytechnic Institute, and obtained her Bachelor of Science, summa cum laude, from the University of Maryland College Park. Prior to entering law school, Sharon worked as a computer systems programmer and instructor at General Electric Plastics and MCI Telecommunications. Sharon received her Juris Doctor degree, with honors, from the University of Maryland School of Law in 1992, where she was an Assistant Editor of the Maryland Law Review. Sharon also studied at the Université Paris Sorbonne (Paris IV), in Paris, France, where she received a Certificate in European Legal Studies in 1990.